Hi, Brian.

Recently, I have seen ads for the new immunotherapy drug, Opdiva, as being one to prolong the lives of those with advanced stage SCC in the lungs.

Since you are right on top of these things, I was wondering if you have heard if it would potentially benefit certain patients with lungs mets or OC/OPC in general.

Just curious smile.

Best,
Kerri

37 y/o fem at Dx (23 wks preg @ dx on 3/16/11)
SCC L oral tongue (no risk factors)
L partial gloss/MND 3/28/11 @ 25 wks preg
T1-2N0M0; no rads/chemo
Tonsillectomy on 8/6/12 +SCC L tonsil T2-3N1M0 (HPV-)
Treated with 35 rads/7 carbo & taxol (Rx ended 10/31/12), but many hospitalizations d/t complications from rx.
Various scans since rx ended are NED!
Part of genetic study for rare cancers @ MGH.
44 years old now...I wasn't sure I would make it! Hoping for 40 more!